Baxter International Inc Total Assets

Latest as of June 2026: $19.79 Billion USD

Baxter International Inc total assets. Based on the latest financial reports, Baxter International Inc (BAX) holds total assets worth $19.79 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BAX cash flow conversion for how efficiently the company converts equity into cash flow.

Total Assets of Baxter International Inc (1985–2025)

Total assets of Baxter International Inc from 1985 to 2025. This chart illustrates how Baxter International Inc's total assets have evolved over time, based on quarterly financial data. See Baxter International Inc stock price for real-time trading data and today's change.

Baxter International Inc - Asset Composition Analysis

Baxter International Inc Total Assets Breakdown (December 2025)

Baxter International Inc total assets breakdown as of December 2025. Baxter International Inc's total assets of $19.79 Billion consist of 34.3% current assets and 65.7% non-current assets. Explore BAX net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $1.97 Billion 9.8%
Accounts Receivable $1.93 Billion 9.6%
Inventory $2.23 Billion 11.1%
Property, Plant & Equipment $3.19 Billion 15.9%
Intangible Assets $4.37 Billion 21.8%
Goodwill $4.93 Billion 24.6%

Asset Composition Trend (1985–2025)

This chart illustrates how Baxter International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Baxter International Inc's current assets represent 34.3% of total assets in 2025, a decrease from 34.6% in 1985.
  • Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, up from 4.0% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 34.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 24.6% of total assets.

Baxter International Inc Competitors by Total Assets

Key competitors of Baxter International Inc based on total assets are shown below.

Company Country Total Assets
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
Autek China Inc
SHE:300595
China CN¥6.40 Billion
Mingyue Optical Lens Co.Ltd.
SHE:301101
China CN¥2.09 Billion
Pegavision
TW:6491
Taiwan NT$16.17 Billion
St.Shine Optical Co Ltd
TWO:1565
Taiwan NT$7.81 Billion
Interojo Inc
KQ:119610
Korea ₩252.22 Billion
Ocumetics Technology Corp
V:OTC
Canada CA$1.15 Million
SDI Ltd
AU:SDI
Australia AU$135.84 Million

Baxter International Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.95 2.30 2.37
Quick Ratio 1.32 1.49 1.78
Cash Ratio 0.00 0.57 0.95
Working Capital $3.40 Billion $3.81 Billion $4.73 Billion

Baxter International Inc - Advanced Valuation Insights

This section examines the relationship between Baxter International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.30
Latest Market Cap to Assets Ratio 0.64
Asset Growth Rate (YoY) -22.2%
Total Assets $20.05 Billion
Market Capitalization $12.88 Billion USD

Valuation Analysis

Below Book Valuation: The market values Baxter International Inc's assets below their book value (0.64x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Baxter International Inc's assets decreased by 22.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Baxter International Inc (1985–2025)

The table below shows the annual total assets of Baxter International Inc from 1985 to 2025.

Year Total Assets Change
2025-12-31 $20.05 Billion -22.21%
2024-12-31 $25.78 Billion -8.82%
2023-12-31 $28.28 Billion -0.04%
2022-12-31 $28.29 Billion -15.61%
2021-12-31 $33.52 Billion +67.45%
2020-12-31 $20.02 Billion +10.04%
2019-12-31 $18.19 Billion +15.73%
2018-12-31 $15.72 Billion -8.13%
2017-12-31 $17.11 Billion +10.07%
2016-12-31 $15.55 Billion -25.84%
2015-12-31 $20.96 Billion -19.80%
2014-12-31 $26.14 Billion +3.62%
2013-12-31 $25.22 Billion +23.71%
2012-12-31 $20.39 Billion +6.91%
2011-12-31 $19.07 Billion +9.06%
2010-12-31 $17.49 Billion +0.78%
2009-12-31 $17.35 Billion +12.65%
2008-12-31 $15.40 Billion +0.73%
2007-12-31 $15.29 Billion +4.14%
2006-12-31 $14.69 Billion +15.39%
2005-12-31 $12.73 Billion -10.04%
2004-12-31 $14.15 Billion +3.21%
2003-12-31 $13.71 Billion +9.85%
2002-12-31 $12.48 Billion +20.64%
2001-12-31 $10.34 Billion +18.44%
2000-12-31 $8.73 Billion -9.45%
1999-12-31 $9.64 Billion -2.32%
1998-12-31 $9.87 Billion +13.39%
1997-12-31 $8.71 Billion +14.63%
1996-12-31 $7.60 Billion -19.51%
1995-12-31 $9.44 Billion -5.65%
1994-12-31 $10.00 Billion -5.15%
1993-12-31 $10.54 Billion +15.18%
1992-12-31 $9.15 Billion -1.98%
1991-12-31 $9.34 Billion +9.66%
1990-12-31 $8.52 Billion +0.16%
1989-12-31 $8.50 Billion -0.55%
1988-12-31 $8.55 Billion +11.94%
1987-12-31 $7.64 Billion +8.06%
1986-12-31 $7.07 Billion +3.35%
1985-12-31 $6.84 Billion --

About Baxter International Inc

NYSE:BAX USA Medical Instruments & Supplies
Market Cap
$12.88 Billion
Market Cap Rank
#1790 Global
#690 in USA
Share Price
$24.92
Change (1 day)
-1.46%
52-Week Range
$15.80 - $28.35
All Time High
$85.36
About

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more